We are live on ! Find out more
OM icon

Outset Medical

152 hedge funds and large institutions have $584M invested in Outset Medical in 2023 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 51 increasing their positions, 51 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more call options, than puts

Call options by funds: $1.32M | Put options by funds: $1.19M

0.02% more ownership

Funds ownership: 7.18%7.2% (+0.02%)

0% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 51

1% less funds holding

Funds holding: 153152 (-1)

4% less first-time investments, than exits

New positions opened: 25 | Existing positions closed: 26

50% less capital invested

Capital invested by funds: $1.16B → $584M (-$574M)

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
152
Holders Change
-1
Holders Change %
-0.65%
% of All Funds
2.41%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
25
Increased
51
Reduced
51
Closed
26
Calls
$1.32M
Puts
$1.19M
Net Calls
+$133K
Net Calls Change
-$219K

OM Hedge Fund Activity: Q3 2023 in Review

152 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Outset Medical (OM) for Q3 2023, worth a combined $584M — down 50% from $1.16B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of OM and 25 opened new positions — a net loss of 1 holder — while 51 trimmed existing stakes and 51 added.

The largest buyer was Morgan Stanley, adding an estimated $16.5M. The largest seller was Bellevue Group, cutting an estimated $11.3M.

  • 152 institutional investors held Outset Medical (OM) as of Q3 2023, down from 153 in Q2 2023.
  • Funds reported $584M of Outset Medical stock for Q3 2023, down 50% quarter-over-quarter.
  • 25 funds opened new Outset Medical positions in Q3 2023 and 26 closed out, a net change of -1 holder.
  • The largest Outset Medical buyer in Q3 2023 was Morgan Stanley, an estimated $16.5M added.
  • The largest Outset Medical seller in Q3 2023 was Bellevue Group, an estimated $11.3M sold.

Based on aggregated 13F filings for Q3 2023.